FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Tuesday

 

Tackling progressive MS

Associate Professor David Brown
A new 2014 MS Research Australia project grant holds particular promise for tackling the progressive forms of MS. This is an important area of research, since there are currently no treatment options for these forms of the disease.
Associate Professor David Brown at the University of NSW, has been awarded $250,000 over three years, co-funded by the Trish MS Research Foundation, to investigate a molecule known as MIC-1/GDF15 that appears to play a key role in regulating cells of the innate immune system.
The innate immune system is generally the ‘first line’ of defence against perceived threats to the body. It is also involved in longer term clean-up and repair responses to damage. The attention of many researchers has increasingly been turning to the role of the innate immune system in MS as it appears to play a significant role in the ‘slow-burning’ accumulation of myelin and nerve damage that occurs in progressive forms of MS.
The research program discovered the MIC-1/GDF15 molecule, and as a result of this research, the molecule is now being developed internationally as a new therapy for a number of diseases including obesity and inflammation. Preliminary evidence from his laboratory suggests that MIC-1/GDF15 also modulates the innate immune system and that it may be an effective treatment for progressive MS.
The focus of this project will be the mechanisms by which MIC-1/GDF15 regulates the cells of the innate immune system, such as dendritic cells and the microglial cells of the brain. He also aims to use laboratory models of MS to obtain evidence that MIC-1/GDF15 could be used as a therapeutic agent in autoimmune disease.
Since MIC-1/GDF15 is about to enter Phase I clinical trials for appetite suppression, much of the safety work in humans is underway. This means that if Associate Professor Brown can confirm a role for MIC-1/GDF15 in MS there will be an exciting opportunity to rapidly progress his experimental results into direct benefits for people with progressive forms of MS.
With his considerable experience with this molecule and the tools and methods already developed at the University of NSW, Associate Professor Brown is well positioned to make rapid progress on this exciting project.
Click here to read more


Go to Newer News Go to Older News